|
1
|
Yu MC and Yuan JM: Epidemiology of
nasopharyngeal carcinoma. Semin Cancer Biol. 12:421–429. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wei WI and Sham JS: Nasopharyngeal
carcinoma. Lancet. 365:2041–2054. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen L, Hu CS, Chen XZ, et al: Concurrent
chemoradiotherapy plus adjuvant chemotherapy versus concurrent
chemoradiotherapy alone in patients with locoregionally advanced
nasopharyngeal carcinoma: a phase 3 multicentre randomised
controlled trial. Lancet Oncol. 13:163–171. 2012. View Article : Google Scholar
|
|
4
|
Zhou J, Wang L, Xu X, Tu Y, Qin S and Yin
Y: Antitumor activity of Endostar combined with radiation against
human nasopharyngeal carcinoma in mouse xenograft models. Oncol
Lett. 4:976–980. 2012.PubMed/NCBI
|
|
5
|
Luftig M: Heavy LIFting: tumor promotion
and radioresistance in NPC. J Clin Invest. 123:4999–5001. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shaw RJ: Metformin trims fats to restore
insulin sensitivity. Nat Med. 19:1570–1572. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Evans JM, Donnelly LA, Emslie-Smith AM,
Alessi DR and Morris AD: Metformin and reduced risk of cancer in
diabetic patients. BMJ. 330:1304–1305. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Landman GW, Kleefstra N, van Hateren KJ,
Groenier KH, Gans RO and Bilo HJ: Metformin associated with lower
cancer mortality in type 2 diabetes: ZODIAC-16. Diabetes Care.
33:322–326. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Singh S, Singh PP, Singh AG, Murad MH and
Sanchez W: Antidiabetic medications and the risk of hepatocellular
cancer: a systematic review and meta-analysis. Am J Gastroenterol.
108:881–891. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ben SI, Le Marchand-Brustel Y, Tanti JF
and Bost F: Metformin in cancer therapy: a new perspective for an
old antidiabetic drug? Mol Cancer Ther. 9:1092–1099. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiralerspong S, Palla SL, Giordano SH, et
al: Metformin and pathologic complete responses to neoadjuvant
chemotherapy in diabetic patients with breast cancer. J Clin Oncol.
27:3297–3302. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Iliopoulos D, Hirsch HA and Struhl K:
Metformin decreases the dose of chemotherapy for prolonging tumor
remission in mouse xenografts involving multiple cancer cell types.
Cancer Res. 71:3196–3201. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sanli T, Rashid A, Liu C, et al: Ionizing
radiation activates AMP-activated kinase (AMPK): a target for
radiosensitization of human cancer cells. Int J Radiat Oncol Biol
Phys. 78:221–229. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Song CW, Lee H, Dings RP, et al: Metformin
kills and radio-sensitizes cancer cells and preferentially kills
cancer stem cells. Sci Rep. 2:3622012.PubMed/NCBI
|
|
15
|
Liu J, Hou M, Yuan T, et al: Enhanced
cytotoxic effect of low doses of metformin combined with ionizing
radiation on hepatoma cells via ATP deprivation and inhibition of
DNA repair. Oncol Rep. 28:1406–1412. 2012.PubMed/NCBI
|
|
16
|
Xu Z, Fang S, Zuo Y, et al: Combination of
pigment epithelium-derived factor with radiotherapy enhances the
antitumor effects on nasopharyngeal carcinoma by downregulating
vascular endothelial growth factor expression and angiogenesis.
Cancer Sci. 102:1789–1798. 2011. View Article : Google Scholar
|
|
17
|
Skinner HD, Sandulache VC, Ow TJ, et al:
TP53 disruptive mutations lead to head and neck cancer treatment
failure through inhibition of radiation-induced senescence. Clin
Cancer Res. 18:290–300. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Skinner HD, McCurdy MR, Echeverria AE, et
al: Metformin use and improved response to therapy in esophageal
adenocarcinoma. Acta Oncol. 52:1002–1009. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin ZZ, Chou CH, Cheng AL, Liu WL and
Chia-Hsien Cheng J: Radiosensitization by combining an aurora
kinase inhibitor with radiotherapy in hepatocellular carcinoma
through cell cycle interruption. Int J Cancer. 135:492–501. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Grosse J, Warnke E, Wehland M, et al:
Mechanisms of apoptosis in irradiated and sunitinib-treated
follicular thyroid cancer cells. Apoptosis. 19:480–490. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Storozhuk Y, Hopmans SN, Sanli T, et al:
Metformin inhibits growth and enhances radiation response of
non-small cell lung cancer (NSCLC) through ATM and AMPK. Br J
Cancer. 108:2021–2032. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jackson SP: Sensing and repairing DNA
double-strand breaks. Carcinogenesis. 23:687–696. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bonner WM, Redon CE, Dickey JS, et al:
GammaH2AX and cancer. Nat Rev Cancer. 8:957–967. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bourton EC, Plowman PN, Smith D, Arlett CF
and Parris CN: Prolonged expression of the γ-H2AX DNA repair
biomarker correlates with excess acute and chronic toxicity from
radiotherapy treatment. Int J Cancer. 129:2928–2934. 2011.
|
|
25
|
Sandulache VC, Skinner HD, Ow TJ, et al:
Individualizing anti-metabolic treatment strategies for head and
neck squamous cell carcinoma based on TP53 mutational status.
Cancer. 118:711–721. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Truman JP, Gueven N, Lavin M, et al:
Down-regulation of ATM protein sensitizes human prostate cancer
cells to radiation-induced apoptosis. J Biol Chem. 280:23262–23272.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Biddlestone-Thorpe L, Sajjad M, Rosenberg
E, et al: ATM kinase inhibition preferentially sensitizes
p53-mutant glioma to ionizing radiation. Clin Cancer Res.
19:3189–3200. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gil del Alcazar CR, Hardebeck MC,
Mukherjee B, et al: Inhibition of DNA double-strand break repair by
the dual PI3K/ mTOR inhibitor NVP-BEZ235 as a strategy for
radiosensitization of glioblastoma. Clin Cancer Res. 20:1235–1248.
2013.PubMed/NCBI
|
